Adapthealth Corp (AHCO)vsEli Lilly and Company (LLY)
AHCO
Adapthealth Corp
$5.64
+1.26%
HEALTHCARE · Cap: $761.77M
LLY
Eli Lilly and Company
$1,183.46
+0.13%
HEALTHCARE · Cap: $1.03T
Smart Verdict
WallStSmart Research — data-driven comparison
Eli Lilly and Company generates 2269% more annual revenue ($79.67B vs $3.36B). LLY leads profitability with a 33.5% profit margin vs -6.8%. LLY earns a higher WallStSmart Score of 76/100 (B+).
AHCO
Hold47
out of 100
Grade: D+
LLY
Strong Buy76
out of 100
Grade: B+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+67.3%
Fair Value
$32.23
Current Price
$5.64
$26.59 discount
Intrinsic value data unavailable for LLY.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Mega-cap, among the largest globally
Every $100 of equity generates 79 in profit
Keeps 34 of every $100 in revenue as profit
Strong operational efficiency at 54.2%
Revenue surging 47.7% year-over-year
Earnings expanding 26.2% YoY
Areas to Watch
Smaller company, higher risk/reward
Operating margin of 0.8%
Elevated debt levels
ROE of -16.6% — below average capital efficiency
Premium valuation, high expectations priced in
Elevated debt levels
Trading at 31.1x book value
Comparative Analysis Report
WallStSmart ResearchBull Case : AHCO
The strongest argument for AHCO centers on Price/Book. Revenue growth of 12.7% demonstrates continued momentum.
Bull Case : LLY
The strongest argument for LLY centers on Market Cap, Return on Equity, Profit Margin. Profitability is solid with margins at 33.5% and operating margin at 54.2%. Revenue growth of 47.7% demonstrates continued momentum.
Bear Case : AHCO
The primary concerns for AHCO are Market Cap, Operating Margin, Debt/Equity.
Bear Case : LLY
The primary concerns for LLY are P/E Ratio, Debt/Equity, Price/Book. Debt-to-equity of 1.62 is elevated, increasing financial risk.
Key Dynamics to Monitor
AHCO profiles as a turnaround stock while LLY is a growth play — different risk/reward profiles.
AHCO carries more volatility with a beta of 1.39 — expect wider price swings.
LLY is growing revenue faster at 47.7% — sustainability is the question.
LLY generates stronger free cash flow (7.8B), providing more financial flexibility.
Bottom Line
LLY scores higher overall (76/100 vs 47/100), backed by strong 33.5% margins and 47.7% revenue growth. AHCO offers better value entry with a 67.3% margin of safety. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Adapthealth Corp
HEALTHCARE · MEDICAL DEVICES · USA
AdaptHealth Corp. The company is headquartered in Plymouth Meeting, Pennsylvania.
Visit Website →Eli Lilly and Company
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries.
Visit Website →Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?